Patents-Review.com
ClassID:

110809 ⎘

C12N2760/16121 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus Viruses as such, e.g. new isolates, mutants or their genomic sequences

Recent Application in this class:
#1
20260071191
2026-03-12

MODIFIED INFLUENZA VIRUSES

 #2
20260061044
2026-03-05

Mutated Influenza Virus, Pharmaceutical Composition, and Use

 #3
20260034205
2026-02-05

MODIFIED LIVE ATTENUATED FLU VIRUS VACCINES AND USES THEREOF

 #4
20250313813
2025-10-09

RATIONALLY DESIGNED SINGLE-ROUND INFECTIOUS VIRUS AND METHODS OF USE THEREOF

 #5
20250277192
2025-09-04

RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NA

 #6
20250255955
2025-08-14

DUAL FUNCTION ANTIGEN BINDING MOLECULES

 #7
20250090649
2025-03-20

INFLUENZA VIRUS MUTANTS AND USES THEREFOR

 #8
20250034214
2025-01-30

INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT

 #9
20240352442
2024-10-24

METHOD FOR ATTENUATING INFLUENZA VIRUS BY SYNONYMOUS MUTATION AND DELETION MUTATION, AND ATTENUATED INFLUENZA VIRUS STRAIN AND USE

 #10
20240301007
2024-09-12

METHODS AND COMPOSITIONS FOR QUADRIVALENT INFLUENZA VACCINE

 #11
20240287466
2024-08-29

CONSTRUCTION AND APPLICATION OF RECOMBINANT H5N8 SUBTYPE AVIAN INFLUENZA VIRUS CARRYING MAPPLE FLUORESCENCE REPORTER GENE

 #12
20240238403
2024-07-18

INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT

 #13
20240228981
2024-07-11

ATTENUATED VIRUSES USEFUL FOR VACCINES

 #14
20240150409
2024-05-09

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

 #15
20240091337
2024-03-21

INFLUENZA B VIRUS MUTANTS AND USES THEREFOR

 #16
20240084267
2024-03-14

COMPOSITIONS AND METHODS FOR THE GENETIC MANIPULATION OF THE INFLUENZA VIRUS

 #17
20240010995
2024-01-11

RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED NA

 #18
20230381294
2023-11-30

Destroying Cancer Cells While Maintaining Healthy Cell Integrity

 #19
20230348864
2023-11-02

INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES

 #20
20230295582
2023-09-21

INFLUENZA VIRUS BACKBONE

 #21
20230285537
2023-09-14

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

 #22
20230192775
2023-06-22

Influenza virus replication for vaccine development

 #23
20230158136
2023-05-25

VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF

 #24
20230147673
2023-05-11

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

 #25
20230000971
2023-01-05

METHOD FOR PRODUCING REASSORTANT INFLUENZA VIRUSES

 #26
20220409719
2022-12-29

Influenza virus mutants and uses therefor

 #27
20220380410
2022-12-01

Live Attenuated Universal Influenza Virus Vaccines, Methods and Uses Thereof

 #28
20220372081
2022-11-24

Whole avian-origin reverse genetic system and recombinant H5N2 subtype avian influenza virus, vaccine and uses thereof

 #29
20220370594
2022-11-24

Whole avian-origin reverse genetic system and its use in producing H7N9 subtype avian influenza vaccine

 #30
20220348959
2022-11-03

RNA VIRUS VECTORS CARRYING DAI AND RIPK3

 #31
20220226463
2022-07-21

RECOMBINANT NON-STRUCTURAL PROTEIN 1, RECOMBINANT INFLUENZA VIRUS AND IMMUNOLOGICAL COMPOSITION INCLUDING THE SAME, AND METHOD OF TREATING OR PREVENTING DISEASE OR CONDITION CAUSED BY OR ASSOCIATED WITH INFLUENZA VIRUS

 #32
20220202929
2022-06-30

DRUG-RESISTANT INFLUENZA VIRUS STRAINS

 #33
20220200559
2022-06-23

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

 #34
20220105171
2022-04-07

Materials and methods for respiratory disease control in canines

 #35
20220096621
2022-03-31

Heat-resistant H1N1 subtype influenza virus mutant strain, preparation method and application thereof

 #36
20220048972
2022-02-17

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER

 #37
20220041997
2022-02-10

Method for rescuing influenza virus and composition therefor

 #38
20220025339
2022-01-27

Mutations that confer genetic stability to additional genes in influenza viruses

 #39
20220003767
2022-01-06

METHOD

 #40
20210299249
2021-09-30

Recombinant multivalent influenza viruses

 #41
20210260179
2021-08-26

MOSAIC INFLUENZA VIRUS HEMAGGLUTININ POLYPEPTIDES AND USES THEREOF

 #42
20210246432
2021-08-12

Recombinant influenza viruses with stabilized NA

 #43
20210244810
2021-08-12

Recombinant H7N9 subtype avian influenza virus, inactivated marked vaccine and preparation method thereof

 #44
20210225457
2021-07-22

METHODS FOR GENERATING PAN-EPITOPIC IMMUNOGENS OF INFLUENZA H3 VIRUS, COMPOSITIONS AND METHODS OF USE THEREOF

 #45
20210206812
2021-07-08

Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses

 #46
20210101458
2021-04-08

Fabric top for a convertible vehicle and convertible vehicle

 #47
20210061862
2021-03-04

Influenza virus replication for vaccine development

 #48
20200385431
2020-12-10

REPLICATION-LIMITED MUCOSAL IMMUNE VACCINE FOR INFLUENZA VIRUS

 #49
20200325182
2020-10-15

Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods

 #50
20200282045
2020-09-10

Influenza B virus mutants and uses therefor

 #51
20200263143
2020-08-20

Influenza viruses with mutant PB2 gene segment as live attenuated vaccines

 #52
20200172877
2020-06-04

INFLUENZA VIRUS REASSORTMENT

 #53
20200129612
2020-04-30

Genome-wide identification of immune evasion functions in a virus

 #54
20200061182
2020-02-27

Influenza virus mutants and uses therefor

 #55
20200000909
2020-01-02

INFLUENZA VIRUS REASSORTMENT

 #56
20190341901
2019-11-07

Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

 #57
20190328863
2019-10-31

Recombinant virus, composition comprising the same, and uses thereof

 #58
20190314488
2019-10-17

Materials and methods for respiratory disease control in canines

 #59
20190224305
2019-07-25

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

 #60
20190211359
2019-07-11

RNA virus vectors carrying DAI and RIPK3

 #61
20190125860
2019-05-02

Equine influenza virus live attenuated vaccines

 #62
20190091324
2019-03-28

NASAL INFLUENZA VACCINE COMPOSITION

 #63
20190085302
2019-03-21

Key phosphorylation site of temperature sensitivity of influenza A virus and use thereof

 #64
20190060441
2019-02-28

Influenza virus mutants and uses therefor

 #65
20190048324
2019-02-14

HIGH TITER RECOMBINANT INFLUENZA VIRUSES FOR VACCINES

 #66
20190032023
2019-01-31

Influenza virus replication for vaccine development

 #67
20190010469
2019-01-10

Attenuated viruses useful for vaccines

 #68
20180369363
2018-12-27

Genetically engineered swine influenza virus and uses thereof

 #69
20180369361
2018-12-27

Compositions and methods for vaccination against influenza A virus

 #70
20180326040
2018-11-15

INFLUENZA VIRUS VACCINE AND VACCINE PLATFORM

 #71
20180296664
2018-10-18

H3 influenza A virus

 #72
20180291351
2018-10-11

Recombinant Influenza Viruses for Vaccines and Gene Therapy

 #73
20180289795
2018-10-11

Bivalent swine influenza virus vaccine

 #74
20180256703
2018-09-13

Single-cycle virus for the development of canine influenza vaccines

 #75
20180245054
2018-08-30

Mutations that confer genetic stability to additional genes in influenza viruses

 #76
20180245052
2018-08-30

Attenuated influenza vectors for the prevention and/or treatment of infectious diseases and for the treatment of oncological diseases

 #77
20180194829
2018-07-12

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER

 #78
20180177862
2018-06-28

Antigenically matched influenza vaccines

 #79
20180169217
2018-06-21

Materials and methods for respiratory disease control in canines

 #80
20180021427
2018-01-25

H3 influenza A virus

 #81
20180016560
2018-01-18

NOVEL INFLUENZA VIRUS

 #82
20170354730
2017-12-14

High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs

 #83
20170326227
2017-11-16

Influenza virus reassortment

 #84
20170252428
2017-09-07

Inactivated equine influenza virus vaccines

 #85
20170204479
2017-07-20

Influenza A virus variants

 #86
20170204478
2017-07-20

Influenza A virus variants

 #87
20170198264
2017-07-13

Recombinant Influenza Viruses for Vaccines and Gene Therapy

 #88
20170151324
2017-06-01

Genetically engineered swine influenza virus and uses thereof

 #89
20170151323
2017-06-01

Recombinant swine influenza virus and uses thereof

 #90
20170106078
2017-04-20

H3 influenza A virus

 #91
20170096645
2017-04-06

Influenza M2 protein mutant viruses as live influenza attenuated vaccines

 #92
20170095549
2017-04-06

Influenza virus reassortment

 #93
20170067030
2017-03-09

Methods of making modified viral genomes

 #94
20170067029
2017-03-09

Influenza virus replication for vaccine development

 #95
20160362454
2016-12-15

Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses

 #96
20160355790
2016-12-08

Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA

 #97
20160348144
2016-12-01

Methods for producing virus particles with simplified glycosylation of surface proteins

 #98
20160303222
2016-10-20

Compositions and methods for vaccination against influenza A virus

 #99
20160289304
2016-10-06

Hybrid influenza seed viruses, compositions thereof, and use thereof in the diagnosis or therapy of influenza

 #100
20160279227
2016-09-29

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

 #101
20160250318
2016-09-01

Bivalent swine influenza virus vaccine

 #102
20160228535
2016-08-11

Influenza virus mutants and uses therefor

 #103
20160228534
2016-08-11

Influenza virus mutants and uses therefor

 #104
20160208223
2016-07-21

High titer recombinant influenza viruses for vaccines

 #105
20160137987
2016-05-19

Recombinant influenza viruses for vaccines and gene therapy

 #106
20160136261
2016-05-19

Live attenuated vaccines for influenza viruses

 #107
20160122726
2016-05-05

Influenza virus reassortment

 #108
20160120973
2016-05-05

Attenuated swine influenza vaccines and methods of making and use thereof

 #109
20160076006
2016-03-17

THERMOSENSITIVE MUTANTS OF INFLUENZA VIRUSES

 #110
20160067328
2016-03-10

Recombinant neuraminidase and uses thereof

 #111
20160051662
2016-02-25

H3 influenza a virus

 #112
20160038583
2016-02-11

INFLUENZA HEMAGGLUTININ VARIANTS AND USES THEREFOR

 #113
20150368621
2015-12-24

Mutations that confer genetic stability to additional genes in influenza viruses

 #114
20150353900
2015-12-10

Influenza virus reassortment

 #115
20150315548
2015-11-05

Influenza virus reassortment

 #116
20150307851
2015-10-29

Influenza viruses with mutant PB2 segment as live attenuated vaccines

 #117
20150273049
2015-10-01

Genetically engineered swine influenza virus and uses thereof

 #118
20150056235
2015-02-26

Materials and methods for respiratory disease control in canines

 #119
20150017205
2015-01-15

High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs

 #120
20140377296
2014-12-25

H3 influenza A virus

 #121
20140341948
2014-11-20

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #122
20140073032
2014-03-13

Batches of recombinant adenovirus with altered terminal ends

 #123
20140044641
2014-02-13

Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer

 #124
20140030291
2014-01-30

Influenza virus reassortment

 #125
20130230552
2013-09-05

Influenza viruses with mutant PB2 gene segment as live attenuated vaccines

 #126
20130164264
2013-06-27

Method of preventing or treating influenza A viral infection using cloned DI influenza A viral particles

 #127
20130115242
2013-05-09

Modified viral strains and method for improving the production of vaccine seeds of influenza virus

 #128
20130115235
2013-05-09

Swine influenza hemagglutinin variants

 #129
20130034581
2013-02-07

Genetically engineered swine influenza virus and uses thereof

 #130
20120258134
2012-10-11

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #131
20120251568
2012-10-04

Recombinant influenza viruses and uses thereof

 #132
20120244600
2012-09-27

Swine influenza hemagglutinin variants

 #133
20120164175
2012-06-28

Influenza virus

 #134
20120156758
2012-06-21

Recombinant influenza viruses for vaccines and gene therapy

 #135
20120034264
2012-02-09

INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

 #136
20110311586
2011-12-22

Materials and methods for respiratory disease control in canines

 #137
20110212117
2011-09-01

Influenza hemagglutinin and neuraminidase variants

 #138
20110143424
2011-06-16

RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY

 #139
20110123559
2011-05-26

Swine influenza hemagglutinin variants

 #140
20110052618
2011-03-03

Influenza hemagglutinin and neuraminidase variants

 #141
20100285063
2010-11-11

Canine influenza virus and vaccine therefore

 #142
20100247572
2010-09-30

VIRUSES ENCODING MUTANT MEMBRANE PROTEIN

 #143
20100233785
2010-09-16

NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES

 #144
20100209454
2010-08-19

Attenuated viruses useful for vaccines

 #145
20100158942
2010-06-24

ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS

 #146
20100062532
2010-03-11

Methods and compositions for increasing replication capacity of an influenza virus

 #147
20100062014
2010-03-11

H3 equine influenza A virus

 #148
20090246830
2009-10-01

RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY

 #149
20090203114
2009-08-13

Methods for the propagation of modified influenza viruses in embryonated eggs

 #150
20090191158
2009-07-30

Cloned defective interfering influenza A virus

 #151
20090175909
2009-07-09

Influenza hemagglutinin and neuraminidase variants

 #152
20090136530
2009-05-28

Influenza hemagglutinin and neuraminidase variants

 #153
20090074812
2009-03-19

Influenza M2 protein mutant viruses as live influenza attenuated vaccines

 #154
20090074804
2009-03-19

Vero cell-based influenza virus strains and vaccines

 #155
20090053264
2009-02-26

Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals

 #156
20090010962
2009-01-08

Genetically engineered swine influenza virus and uses thereof

 #157
20080175863
2008-07-24

Methods and compositions for increasing replication capacity of an influenza virus

 #158
20080075736
2008-03-27

Materials and methods for respiratory disease control in canines

 #159
20080050403
2008-02-28

Production of viruses, viral isolates and vaccines

 #160
20070231348
2007-10-04

High titer recombinant influenza viruses for vaccines

 #161
20060153871
2006-07-13

H3 equine influenza A virus

 #162
20060134138
2006-06-22

System producing infectious recombinant influenza virus

 #163
20060057116
2006-03-16

Recombinant influenza viruses for vaccines and gene therapy

 #164
20060008473
2006-01-12

Influenza hemagglutinin and neuraminidase variants

 #165
20050287172
2005-12-29

Influenza hemagglutinin and neuraminidase variants

 #166
20050123564
2005-06-09

Production of viruses viral isolates and vaccines

 #167
20050054846
2005-03-10

Method for generating influenza viruses and vaccines

 #168
20050054074
2005-03-10

Methods and interferon deficient substrates for the propagation of viruses